WASHINGTON, Jan. 12, 2024 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) submitted a comment letter (here) on January 5, 2024, regarding the FDA’s recently announced policy—by way of a draft guidance document—that substantially restricts drug manufacturers’ ability to…

WASHINGTON, Jan. 12, 2024 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) submitted a comment letter (here) on January 5, 2024, regarding the FDA’s recently announced policy—by way of a draft guidance document—that substantially restricts drug manufacturers’ ability to…

DUBLIN, Jan. 12, 2024 /PRNewswire/ — The “US and EU Indoor Cannabis Gardening Market Highlights 2023-2030: Grow Box Trends, Market Insights, Regulations, and Competitive Benchmarking” report has been added to ResearchAndMarkets.com’s offering. This comprehensive analysis encompasses…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.